As one of the causative agents of lymphatic filariasis in humans, Brugia malayi has been established as the laboratory model of choice for studying this infection owing to its viability in small animal hosts, with the domestic cat being significant among these. The usefulness of individual feline infections is highly dependent on the levels of circulating microfilariae in the blood; thus, characterizing the course of microfilaremia benefits our understanding of this model. In B. malayi-endemic regions, cats are also known reservoirs of infection, and describing microfilaremia in a controlled setting may improve transmission modeling. We followed the course of B. malayi infection in 10 experimentally infected cats from inoculation to ultimate resolution. Seven cats developed patency, with a peak microfilaria concentration of 6525/mL. In addition, to identify cellular responses with potential value as predictors of patency, we measured the peripheral blood leukocyte counts during the first 8 months of infection and tested for correlations with lifelong microfilaria production. No strong relationships were observed, though cell values did appear to shift with the maturation phases of the parasite. The data we present reflect the course of microfilaremia in an important laboratory model under controlled conditions.
Get full access to this article
View all access options for this article.
References
1.
AmbilyVR, PillaiUN, ArunR, PramodS, et al.Detection of human filarial parasite Brugia malayi in dogs by histochemical staining and molecular techniques. Vet Parasitol, 2011; 181:210–214.
2.
AshLR, RileyJM. Development of subperiodic Brugia malayi in the jird, Meriones unguiculatus, with notes on infections in other rodents. J Parasitol, 1970; 56:969–973.
3.
BabuS, BhatSQ, KumarNP, LipiraAB, et al.Filarial lymphedema is characterized by antigen-specific Th1 and Th17 proinflammatory responses and a lack of regulatory T cells. PLoS Negl Trop Dis, 2009; 3:e420.
4.
BabuS, BlauveltCP, KumaraswamiV, NutmanTB. Cutting edge: Diminished T cell TLR expression and function modulates the immune response in human filarial infection. J Immunol, 2006; 176:3885–3889.
5.
BabuS, BlauveltCP, KumaraswamiV, NutmanTB. Diminished expression and function of TLR in lymphatic filariasis: A novel mechanism of immune dysregulation. J Immunol, 2005; 175:1170–1176.
6.
BurrenCH. The behaviour of Brugia malayi microfilariae in experimentally infected domestic cats. Ann Trop Med Parasitol, 1972; 66:235–242.
7.
ChandrasenaNTGA, PremaratnaR, SamarasekeraDS, de SilvaNR. Surveillance for transmission of lymphatic filariasis in Colombo and Gampaha districts of Sri Lanka following mass drug administration. Trans R Soc Trop Med Hyg, 2016; 110:620–622.
8.
ChangMS, HoBC, HardinS, DoraisingamP. Filariasis in Kota Samarahan District Sarawak, East-Malaysia. Trop Biomed, 1992; 9:39.
9.
ChansiriK, TejangkuraT, KwaosakP, SarataphanN, et al.PCR based method for identification of zoonostic Brugia malayi microfilariae in domestic cats. Mol Cell Probes, 2002; 16:129–135.
10.
ChansiriK, YodmekS. Periodicity of Brugia malayi appearance in blood of domestic Thai cats in Surat Thani Province. J Trop Med Parasitol, 2004; 27:15–20.
11.
ChirayathD, AlexPC, GeorgeS, AjithkumarS, et al.Identification of Brugia malayi in dogs in Kerala, India. Trop Biomed, 2017; 34:804–814.
12.
CrandallRB, McGreevyPB, ConnorDH, CrandallCA, et al.The ferret (Mustela putorius furo) as an experimental host for Brugia malayi and Brugia pahangi. Am J Trop Med Hyg, 1982; 31:752–759.
13.
CritchleyJ, AddissD, EjereH, GambleC, et al.Albendazole for the control and elimination of lymphatic filariasis: Systematic review. Trop Med Int Health, 2005; 10:818–825.
14.
CrossJH, PartonoF, HsuMY, AshLR, et al.Experimental transmission of Wuchereria bancrofti to monkeys. Am J Trop Med Hyg, 1979; 28:56–66.
DissanaikeAS. Zoonotic aspects of filarial infections in man. Bull World Health Organ, 1979; 57:349–357.
17.
DissanaikeAS, MakJW. A description of adult Wuchereria bancrofti (rural strain) from an experimental infection in the long-tailed macaque, Macaca fascicularis (sny. M. irus). J Helminthol, 1980; 54:117–122.
18.
Dondero JrTJ, MenonVVV. Clinical epidemiology of filariasis due to Brugia malayi on a rubber estate in West Malaysia. SE Asian J Trop Med Publ Health, 1972; 3:355–365.
19.
DreyerG, AddissD, SantosA, Figueredo-SilvaJ, et al.Direct assessment in vivo of the efficacy of combined single-dose ivermectin and diethylcarbamazine against adult Wuchereria bancrofti. Trans R Soc Trop Med Hyg, 1998; 92:219–222.
20.
EdesonJF, BuckleyJJ. Studies on filariasis in Malaya: On the migration and rate of growth of Wuchereria malayi in experimentally infected cats. Ann Trop Med Parasitol, 1959; 53:113–119.
21.
EdesonJFB, WhartonEH. The transmission of Wuchereria malayi from man to the domestic cat. Trans R Soc Trop Med Hyg, 1957; 51:366–370.
22.
EwertA. Distribution of developing and mature Brugia malayi in cats at various times after a single inoculation. J Parasitol, 1971; 57:1039–1042.
23.
EwertA, FolseD, HillmanG, WangY-X. Effect of diethylcarbamazine citrate on Brugia malayi infections in cats following daily, weekly, or monthly administration. Am J Trop Med Hyg, 1983; 32:385–391.
24.
FreedmanDO. Immune dynamics in the pathogenesis of human lymphatic filariasis. Parasitol Today, 1998; 14:229–234.
25.
GearyTG, WooK, McCarthyJS, MackenzieCD, et al.Unresolved issues in anthelmintic pharmacology for helminthiases of humans. Int J Parasitol, 2010; 40:1–13.
26.
Jackson-ThompsonBM, KimSY, JaiswalS, ScottJR, et al.Brugia malayi infection in ferrets - A small mammal model of lymphatic filariasis. PLoS Negl Trop Dis, 2018; 12:e0006334.
27.
JaokoWG, SimonsenPE, MeyrowitschDW, EstambaleBBA, et al.Filarial-specific antibody response in East African bancroftian filariasis: Effects of host infection, clinical disease, and filarial endemicity. Am J Trop Med Hyg, 2006; 75:97–107.
28.
KingCL, MahantyS, KumaraswamiV, AbramsJS, et al.Cytokine control of parasite-specific anergy in human lymphatic filariasis. Preferential induction of a regulatory T helper type 2 lymphocyte subset. J Clin Invest, 1993; 92:1667–1673.
29.
KingCL, NutmanTB. Regulation of the immune response in lymphatic filariasis and onchocerciasis. Immunol Today, 1991; 12:A54–A58.
30.
KwartengA, AhunoST. Immunity in filarial infections: Lessons from animal models and human studies. Scand J Immunol, 2017; 85:251–257.
31.
LaingABG. Influence of the animal host on the microfilarial periodicity of Brugia malayi. Trans R Soc Trop Med Hyg, 1961; 55:558.
32.
MaizelsRM, HewitsonJP, SmithKA. Susceptibility and immunity to helminth parasites. Curr Opin Immunol, 2012; 24:459–466.
33.
MaizelsRM, LawrenceRA. Immunological tolerance: The key feature in human filariasis?. Parasitol Today, 1991; 7:271–276.
34.
MakJW, YenPK, LimKC, RamiahN. Zoonotic implications of cats and dogs in filarial transmission in Peninsular Malaysia. Trop Geogr Med, 1980; 32:259–264.
35.
MallawarachchiCH, ChandrasenaNTGA, WickramasingheS, PremaratnaR, et al.A preliminary survey of filarial parasites in dogs and cats in Sri Lanka. PLoS One, 2018a; 13.
36.
MallawarachchiCH, Nilmini ChandrasenaTGA, PremaratnaR, MallawarachchiSMNSM, et al.Human infection with sub-periodic Brugia spp. in Gampaha District, Sri Lanka: A threat to filariasis elimination status?. Parasit Vectors, 2018b; 11:68.
37.
MichaelE, GrenfellBT, BundyDAP. The association between microfilaraemia and disease in lymphatic filariasis. Proc R Soc London Ser B Biol Sci, 1994; 256:33–40.
38.
MichalskiML, GriffithsKG, WilliamsSA, KaplanRM, et al.The NIH-NIAID Filariasis Research Reagent Resource Center. PLoS Negl Trop Dis, 2011; 5:e1261.
39.
MitreE, TaylorRT, KubofcikJ, NutmanTB. Parasite antigen-driven basophils are a major source of IL-4 in human filarial infections. J Immunol, 2004; 172:2439–2445.
40.
MukherjeeS, KarnamA, DasM, BabuSPS, et al.Wuchereria bancrofti filaria activates human dendritic cells and polarizes T helper 1 and regulatory T cells via toll-like receptor 4. Commun Biol, 2019; 2:169.
41.
MussoD. Relevance of the eosinophil blood count in bancroftian filariasis as a screening tool for the treatment. Pathog Glob Health, 2013; 107:96–102.
42.
NicolasL, LangyS, PlichartC, DeparisX. Filarial antibody responses in Wuchereria bancrofti transmission area are related to parasitological but not clinical status. Parasite Immunol, 1999; 21:73–80.
43.
NorõesJ, DreyerG, SantosA, MendesVG, et al.Assessment of the efficacy of diethylcarbamazine on adult Wuchereria bancrofti in vivo. Trans R Soc Trop Med Hyg, 1997; 91:78–81.
44.
OttesenEA. Immunological aspects of lymphatic filariasis and onchocerciasis in man. Trans R Soc Trop Med Hyg, 1984; 78:9–18.
45.
PalmieriJR, ConnorDH, Purnomo, MarwotoHA. Bancroftian filariasis. Wuchereria bancrofti infection in the silvered leaf monkey (Presbytis cristatus). Am J Pathol, 1983; 112:383–386.
46.
PalmieriJR, MasbarS, MarwotoHA, TirtokusumoS, et al.The domestic cat as a host for Brugian filariasis in South Kalimantan (Borneo), Indonesia. J Helminthol, 1985; 59:277–281.
47.
PartonoF. Brugia malayi in seven villages in South Kalimantan, Indonesia. Southeast Asian J Trop Med Public Health, 1977; 8:400–407.
48.
PartonoF, Purnomo. Periodicity studies of Brugia malayi in Indonesia: Recent findings and a modified classification of the parasite. Trans R Soc Trop Med Hyg, 1987; 81:657–662.
PhantanaS, ShutidamrongC, ChusattayanondW. Brugia malayi in a cat from southern Thailand. Trans R Soc Trop Med Hyg, 1987; 81:173–174.
51.
PorthouseKH, ChirgwinSR, ColemanSU, TaylorHW, et al.Inflammatory responses to migrating Brugia pahangi third-stage larvae. Infect Immun, 2006; 74:2366 LP–2372.
52.
RamalingamT, PorteP, LeeJ, RajanTV. Eosinophils, but not eosinophil peroxidase or major basic protein, are important for host protection in experimental Brugia pahangi infection. Infect Immun, 2005; 73:8442–8443.
53.
RavindranR, VargheseS, NairSN, BalanVM, et al.Canine filarial infections in a human Brugia malayi endemic area of India. Biomed Res Int, 2014; 2014:630160.
54.
SasaM. A review on classification and geographic distribution of brugian filariasis, Joint WPRO/SEARO Working Group on Brugian Filariasis, Geneva, 1979.
55.
SatjawongvanitH, PhumeeA, TiawsirisupS, SungpraditS, et al.Molecular analysis of canine filaria and its Wolbachia endosymbionts in domestic dogs collected from two animal university hospitals in Bangkok Metropolitan Region, Thailand. Pathogens (Basel, Switzerland), 2019; 8:114.
56.
SchacherJF, SahyounPF. A chronological study of the histopathology of filarial disease in cats and dogs caused by Brugia pahangi (Buckley and Edeson, 1956). Trans R Soc Trop Med Hyg, 1967; 61:234–243.
57.
SemnaniRT, LawM, KubofcikJ, NutmanTB. Filaria-induced immune evasion: Suppression by the infective stage of Brugia malayi at the earliest host-parasite interface. J Immunol, 2004; 172:6229–6238.
58.
SemnaniRT, LiuAY, SabzevariH, KubofcikJ, et al.Brugia malayi microfilariae induce cell death in human dendritic cells, inhibit their ability to make IL-12 and IL-10, and reduce their capacity to activate CD4+ T cells. J Immunol, 2003; 171:1950–1960.
59.
SemnaniRT, VenugopalPG, LeiferCA, MostböckS, et al.Inhibition of TLR3 and TLR4 function and expression in human dendritic cells by helminth parasites. Blood, 2008; 112:1290–1298.
60.
SimónF, González-MiguelJ, DiosdadoA, GómezPJ, et al.The complexity of zoonotic filariasis episystem and its consequences: A multidisciplinary view. Biomed Res Int, 2017; 2017:6436130.
61.
SimonsJE, RothenbergME, LawrenceRA. Eotaxin-1-regulated eosinophils have a critical role in innate immunity against experimental Brugia malayi infection. Eur J Immunol, 2005; 35:189–197.
62.
SubramanianS, StolkWA, RamaiahKD, PlaisierAP, et al.The dynamics of Wuchereria bancrofti infection: A model-based analysis of longitudinal data from Pondicherry, India. Parasitology, 2004; 128:467–482.
63.
TefferiA. Blood eosinophilia: A new paradigm in disease classification, diagnosis, and treatment. Mayo Clin Proc, 2005; 80:75–83.
64.
TorreroMN, HübnerMP, LarsonD, KarasuyamaH, et al.Basophils amplify type 2 immune responses, but do not serve a protective role, during chronic infection of mice with the filarial nematode Litomosoides sigmodontis. J Immunol, 2010; 185:7426–7434.
65.
TurnerP, CopemanB, GerisiD, SpeareR. A comparison of the Og4C3 antigen capture ELISA, the Knott test, an IgG4 assay and clinical signs, in the diagnosis of Bancroftian filariasis. Trop Med Parasitol Off organ Dtsch Tropenmedizinische Gesellschaft Dtsch Gesellschaft fur Tech Zusammenarbeit, 1993; 44:45.
66.
VanamailP, SubramanianS, DasPK, PaniSP, et al.Estimation of age-specific rates of acquisition and loss of Wuchereria bancrofti infection. Trans R Soc Trop Med Hyg, 1989; 83:689–693.
67.
WHO Country Office for Sri Lanka. WHO Officially declares Sri Lanka Filariasis free. World Health Organization, Colombo, 2016.
68.
WongkamchaiS, NochoteH, FoongladdaS, DekumyoyP, et al.A high resolution melting real time PCR for mapping of filaria infection in domestic cats living in brugian filariosis-endemic areas. Vet Parasitol, 2014; 201:120–127.
69.
World Health Organization. Lymphatic filariasis [WWW Document] 2018. https://www.who.int/news-room/fact-sheets/detail/lymphatic-filariasis
